Drug major Cipla Friday posted 10.28 per cent rise in consolidated net profit at Rs 485.35 crore for the first quarter ended June 30, 2013, on account of robust sales growth in domestic as well as export markets.

Pharma major Cipla Ltd plans to invest Rs 500 crore for setting up an active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Kurkumbh.

The setting up of these facilities